Interleukin (IL)-6 and IL-10 are up regulated in late stage Trypanosoma brucei rhodesiense sleeping sickness

PLoS Neglected Tropical Diseases

Volumn 9, Issue 6, 2015, Pages

  Kato, Charles D ^a   Alibu, Vincent P ^a   Nanteza, Ann ^a   Mugasa, Claire M ^a   Matovu, Enock ^a  

^a MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AFRICAN TRYPANOSOMIASIS; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CONVULSION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NONHUMAN; PARASITEMIA; PSYCHOSIS; SENSITIVITY AND SPECIFICITY; SLEEP DISORDER; TREMOR; TRYPANOSOMA BRUCEI RHODESIENSE; UPREGULATION; URINE INCONTINENCE; ADOLESCENT; GENETICS; METABOLISM; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; BIOMARKERS; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN; UP-REGULATION; YOUNG ADULT;

EID: 84934779976     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003835     Document Type: Article

References (48)

1. Simarro PP, Cecchi G, Franco JR, Paone M, Diarra A, Ruiz-Postigo JA, et al. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl Trop Dis. 2012; 6: e1859. doi: 10. 1371/journal. pntd. 0001859 PMID: 23145192
2. Welburn SC, Fèvre EM, Coleman PG, Odiit M, Maudlin I. Sleeping sickness: a tale of two diseases. Trends Parasitol. 2001; 17: 19-24. PMID: 11137736
3. MacLean L, Chisi JE, Odiit M, Gibson WC, Ferris V, Picozzi K, et al. Severity of human African trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile. Infect Immun. 2004; 72: 7040-7044. PMID: 15557627
4. MacLean LM, Odiit M, Chisi JE, Kennedy PG, Sternberg JM. Focus-Specific Clinical Profiles in Human African Trypanosomiasis Caused by Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis. 2010; 4: e906. doi: 10. 1371/journal. pntd. 0000906 PMID: 21151878
5. MacLean, Odiit M, MacLeod A, Morrison L, Sweeney L, Cooper A, et al. Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-γ response. J Infect Dis. 2007; 196: 1620-1628. PMID: 18008245
6. Sternberg JM, MacLean L. A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence. Parasitology. 2010; 137: 2007-2015. doi: 10. 1017/S0031182010000946 PMID: 20663245
7. Kennedy PG. Cytokines in central nervous system trypanosomiasis: cause, effect or both? Trans R Soc Trop Med Hyg. 2009; 103: 213-214. doi: 10. 1016/j. trstmh. 2008. 08. 013 PMID: 18814893
8. Hertz CJ, Filutowicz H, Mansfield JM. Resistance to the African trypanosomes is IFN-γ dependent. J Immunol. 1998; 161: 6775-6783. PMID: 9862708
9. Russell KL, Ming JE, Patel K, Jukofsky L, Magnusson M, Krantz ID. human and rodent interferon-as a growth factor for trypanosoma brucei. Eur J Immunol. 2005.
10. Sternberg JM, Rodgers J, Bradley B, MacLean L, Murray M, Kennedy PG. Meningoencephalitic African trypanosomiasis: brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology. J Neuroimmunol. 2005; 167: 81-89. PMID: 16054238
11. Namangala B, Noël W, De Baetselier P, Brys L, Beschin A. Relative contribution of interferon-γ and interleukin-10 to resistance to murine African trypanosomosis. J Infect Dis. 2001; 183: 1794-1800. PMID: 11372033
12. Yamey G. Research Ethics and Reporting Standards at PLoS Neglected Tropical Diseases. PLoS Negl Trop Dis. 2007; 1: e69.
13. MacLean L, Odiit M, Sternberg JM. Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients. Trans R Soc Trop Med Hyg 2006; 100: 270-275. PMID: 16343570
14. MacLean L, Reiber H, Kennedy PG, Sternberg JM. Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response. PLoS Negl Trop Dis. 2012; 6: e1857. doi: 10. 1371/journal. pntd. 0001857 PMID: 23145191
15. Chappuis F, Loutan L, Simarro P, Lejon V, Büscher P. Options for field diagnosis of human African trypanosomiasis. Clin Microbiol Rev. 2005; 18: 133-146. PMID: 15653823
16. Kennedy PG. Diagnostic and neuropathogenesis issues in human African trypanosomiasis. Int J Parasitol. 2006; 36: 505-512. PMID: 16546191
17. WHO. Control and surveillance of African trypanosomiasis: report of a WHO expert committee. WHO Tech Rep Ser. 2013; 984: 1-250. PMID: 24552089
18. Balasegaram M, Harris S, Checchi F, Hamel C, Karunakara U. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo. Bull World Health Organ. 2006; 84: 777-782. PMID: 17128357
19. Doua F, Miezan T, Sanon SJ, Boa YF, Baltz T. The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. Am J Trop Med Hyg. 1996; 55: 586-588. PMID: 9025682
20. Ruiz JA, Simarro PP, Josenando T. Control of human African trypanosomiasis in the Quicama focus, Angola. Bull World Health Organ. 2002; 80: 738-745. PMID: 12378293
21. Hainard A, Tiberti N, Robin X, Lejon V, Ngoyi DM, Matovu E, et al. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients. PLoS Negl Trop Dis. 2009; 3: e459. doi: 10. 1371/journal. pntd. 0000459 PMID: 19554086
22. Ngotho M, Kagira J, Jensen H, Karanja S, Farah I, Hau J. Immunospecific immunoglobulins and IL-10 as markers for Trypanosoma brucei rhodesiense late stage disease in experimentally infected vervet monkeys. Trop Med Int Health. 2009; 14: 736-747. doi: 10. 1111/j. 1365-3156. 2009. 02285. x PMID: 19573160
23. Tiberti N, Matovu E, Hainard A, Enyaru JC, Lejon V, Robin X, et al. New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients. Clin Transl Med. 2013; 2: 1. doi: 10. 1186/2001-1326-2-1 PMID: 23369533
24. Lejon V, Roger I, Ngoyi DM, Menten J, Robays J, N'Siesi FX, et al. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis. Clin Infect Dis. 2008; 47: 15-22. doi: 10. 1086/588668 PMID: 18494605
25. Rodgers J. Trypanosomiasis and the brain. Parasitology. 2010; 137: 1995-2006. doi: 10. 1017/ S0031182009991806 PMID: 20028610
26. Woo P. The haematocrit centrifuge technique for the diagnosis of African trypanosomiasis. Acta tropica. 1970; 27: 384-386. PMID: 4396363
27. Mumba Ngoyi D, Menten J, Pyana PP, Büscher P, Lejon V. Stage determination in sleeping sickness: comparison of two cell counting and two parasite detection techniques. Trop Med Int Health. 2013; 18: 778-782. doi: 10. 1111/tmi. 12102 PMID: 23506188
28. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. The Lancet. 1974; 304: 81-84.
29. MacLean L, Odiit M, Sternberg JM. Nitric oxide and cytokine synthesis in human African trypanosomiasis. J Infect Dis. 2001; 184: 1086-1090. PMID: 11574928
30. Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian journal of internal medicine. 2013; 4: 627. PMID: 24009950
31. Buyst H. The epidemiology of sleeping sickness in the historical Luangwa valley. Ann Soc Belg Med Trop. 1977; 57: 349-359. PMID: 345980
32. Courtin D, Jamonneau V, Mathieu JF, Koffi M, Milet J, Yeminanga CS, et al. Comparison of cytokine plasma levels in human African trypanosomiasis. Trop Med Int Health. 2006; 11: 647-653. PMID: 16640617
33. Nyawira Maranga D, Kagira JM, Kinyanjui CK, Muturi Karanja S, Wangari Maina N, Ngotho M. IL-6 is Upregulated in Late-Stage Disease in Monkeys Experimentally Infected with Trypanosoma brucei rhodesiense. Clin Dev Immunol. 2013; 2013.
34. Lejon V, Lardon J, Kenis G, Pinoges L, Legros D, Bisser S, et al. Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment. Trans R Soc Trop Med Hyg. 2002; 96: 329-333. PMID: 12174791
35. Rhind SG, Sabiston BH, Shek PN, Buguet A, Muanga G, Stanghellini A, et al. Effect of melarsoprol treatment on circulating IL-10 and TNF-α levels in human African trypanosomiasis. Clin Immunol. 1997; 83: 185-189. PMID: 9143380
36. Kennedy PG. The continuing problem of human African trypanosomiasis (sleeping sickness). Ann Neurol. 2008; 64: 116-126. doi: 10. 1002/ana. 21429 PMID: 18756506
37. Enanga B, Burchmore R, Stewart M, Barrett M. Sleeping sickness and the brain. Cell Mol Life Sci. 2002; 59: 845-858. PMID: 12088284
38. Hunter C, Jennings F, Kennedy P, Murray M. Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice. Lab Inves. 1992; 67: 635-642. PMID: 1434541
39. Okomo-Assoumou MC, Daulouede S, Lemesre J-L, N'Zila-Mouanda A, Vincendeau P. Correlation of high serum levels of tumor necrosis factor-alpha with disease severity in human African trypanosomiasis. Am J Trop Med Hyg. 1995; 53: 539-543. PMID: 7485714
40. Ngotho M, Maina N, Kagira J, Royo F, Farah IO, Hau J. IL-10 is up regulated in early and transitional stages in vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense. Parasitol Int. 2006; 55: 243-248. PMID: 16901747
41. Penkowa M, Giralt M, Lago N, Camats J, Carrasco J, Hernández J, et al. Astrocyte-targeted expression of IL-6 protects the CNSagainst a focal brain injury. Exp Neuro. 2003; 181: 130-148.
42. Courtin D, Milet J, Jamonneau V, Yeminanga CS, Kumeso VKB, Bilengue CMM, et al. Association between human African trypanosomiasis and the IL6gene in a Congolese population. Infect Genet Evol. 2007; 7: 60-68. PMID: 16720107
43. Van Wagoner NJ, Oh J-W, Repovic P, Benveniste EN. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J Neurosci. 1999; 19: 5236-5244. PMID: 10377335
44. Oh J-W, Van Wagoner NJ, Rose-John S, Benveniste EN. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. J Immunol. 1998; 161: 4992-4999. PMID: 9794436
45. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF- β. Immunol Today. 1989; 10: 258-261. PMID: 2478145
46. Kennedy P. Difficulties in diagnostic staging of human African trypanosomiasis. J Neuroparasitol. 2011; 2: 1-3.
47. Kato CD, Nanteza A, Mugasa C, Edyelu A, Matovu E, Alibu VP. Clinical Profiles, Disease Outcome and Co-Morbidities among T. b. rhodesiense Sleeping Sickness Patients in Uganda. PloS one. 2015; 10: e0118370. doi: 10. 1371/journal. pone. 0118370 PMID: 25719539
48. Guimarães da Costa A, do Valle Antonelli LR, Augusto Carvalho Costa P, Paulo Diniz Pimentel J, Garcia NP, Monteiro Tarragô A, et al. The Robust and Modulated Biomarker Network Elicited by the Plasmodium vivax Infection Is Mainly Mediated by the IL-6/IL-10 Axis and Is Associated with the Parasite Load. J Immunol Res. 2014; 2014.